Healthcare provider profile · identity verified

Rushad Darius Shroff, M.D.

Internal Medicine · LUMBERTON, NC · NPI 1982603775

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	619	176
Atorvastatin Calcium	Atorvastatin Calcium	581	149
Losartan Potassium	Losartan Potassium	535	149
Omeprazole	Omeprazole	519	141
Levothyroxine Sodium	Levothyroxine Sodium	514	115
Gabapentin	Gabapentin	479	100
Rosuvastatin Calcium	Rosuvastatin Calcium	442	122
Lisinopril	Lisinopril	312	85
Famotidine	Famotidine	310	82
Hydrochlorothiazide	Hydrochlorothiazide	270	69
Metformin Hcl	Metformin Hcl	263	75
Meloxicam	Meloxicam	253	80
Fluticasone Propionate	Fluticasone Propionate	243	111
Pantoprazole Sodium	Pantoprazole Sodium	243	59
Trazodone Hcl	Trazodone Hcl	236	50
Metoprolol Succinate	Metoprolol Succinate	233	73
Potassium Chloride	Potassium Chloride	222	66
Albuterol Sulfate Hfa	Albuterol Sulfate	203	68
Eliquis	Apixaban	189	35
Ezetimibe	Ezetimibe	171	46
Furosemide	Furosemide	169	58
Sertraline Hcl	Sertraline Hcl	167	35
Carvedilol	Carvedilol	153	45
Clopidogrel	Clopidogrel Bisulfate	140	29
Pravastatin Sodium	Pravastatin Sodium	140	38
Buspirone Hcl	Buspirone Hcl	136	24
Duloxetine Hcl	Duloxetine Hcl	136	35
Azelastine Hcl	Azelastine Hcl	131	64
Doxycycline Monohydrate	Doxycycline Monohydrate	128	108
Tamsulosin Hcl	Tamsulosin Hcl	120	31
Glipizide	Glipizide	110	29
Ipratropium Bromide	Ipratropium Bromide	109	51
Metformin Hcl Er	Metformin Hcl	109	29
Tramadol Hcl	Tramadol Hcl	107	31
Citalopram Hbr	Citalopram Hydrobromide	104	20
Allopurinol	Allopurinol	102	34
Bupropion Xl	Bupropion Hcl	102	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	91	26
Montelukast Sodium	Montelukast Sodium	89	21
Spironolactone	Spironolactone	89	29
Synthroid	Levothyroxine Sodium	89	23
Hydralazine Hcl	Hydralazine Hcl	85	25
Ozempic	Semaglutide	84	16
Escitalopram Oxalate	Escitalopram Oxalate	82	18
Metoprolol Tartrate	Metoprolol Tartrate	82	23
Simvastatin	Simvastatin	80	24
Pregabalin	Pregabalin	75	25
Januvia	Sitagliptin Phosphate	74	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	68	20
Esomeprazole Magnesium	Esomeprazole Magnesium	67	19
Fluoxetine Hcl	Fluoxetine Hcl	58	14
Lorazepam	Lorazepam	54	17
Mirtazapine	Mirtazapine	54	14
Tizanidine Hcl	Tizanidine Hcl	54	23
Nitroglycerin	Nitroglycerin	53	32
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	45
Donepezil Hcl	Donepezil Hcl	50	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Valacyclovir	Valacyclovir Hcl	50	24
Warfarin Sodium	Warfarin Sodium	50	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	15
Clonazepam	Clonazepam	47	15
Finasteride	Finasteride	46	14
Alprazolam	Alprazolam	44	12
Creon	Lipase/Protease/Amylase	42	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Klor-Con M10	Potassium Chloride	41	17
Triamcinolone Acetonide	Triamcinolone Acetonide	41	28
Azithromycin	Azithromycin	40	34
Meclizine Hcl	Meclizine Hcl	40	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Xarelto	Rivaroxaban	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	33	22
Jardiance	Empagliflozin	33	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	16
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Bumetanide	Bumetanide	27	suppressed
Doxepin Hcl	Doxepin Hcl	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Estradiol	Estradiol	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Valsartan	Valsartan	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Ramipril	Ramipril	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Atenolol	Atenolol	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Prednisone	Prednisone	21	13
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Primidone	Primidone	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Aimovig Autoinjector	Erenumab-Aooe	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Methimazole	Methimazole	14	suppressed
Nystatin	Nystatin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Progesterone	Progesterone, Micronized	14	suppressed
Testosterone	Testosterone	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Propranolol Hcl	Propranolol Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Baclofen	Baclofen	12	suppressed
Diazepam	Diazepam	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Temazepam	Temazepam	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Euthyrox	Levothyroxine Sodium	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error